7,010 reports of this reaction
26.9% of all DOCOSANOL reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for DOCOSANOL, manufactured by Haleon US Holdings LLC. There are 7,010 FDA adverse event reports linking DOCOSANOL to DRUG INEFFECTIVE. This represents approximately 26.9% of all 26,055 adverse event reports for this drug.
Patients taking DOCOSANOL who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is a frequently reported adverse event for DOCOSANOL, accounting for a significant proportion of all reports.
In addition to drug ineffective, the following adverse reactions have been reported for DOCOSANOL:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 7,010 FDA reports for DOCOSANOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 26.9% of all adverse event reports for DOCOSANOL, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking DOCOSANOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.